The figure was reported in a filing made public Monday in the Southern District of New York in the bankruptcy case for OxyContin maker Purdue Pharmaceutical.
The figure was reported in a filing made public Monday in the Southern District of New York in the bankruptcy case for OxyContin maker Purdue Pharmaceutical.